bioRxivMicrobiologyPreprint
Automatic antibiotic resistance prediction in Klebsiella pneumoniae based on MALDI-TOF mass spectra
A. Guerrero-Lopez, C. Sevilla-Salcedo, A. Candela, M. Hernandez-Garcia, E. Cercenado, P. M. Olmos, R. Canton, P. Munoz, V. Gomez-Verdejo, R. del Campo, B. Rodriguez-Sanchez
Abstract
Matrix-Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-TOF) Mass Spectrometry (MS) is a reference method for microbial identification and it can be used to predict Antibiotic Resistance (AR) when combined with artificial intelligence methods. However, current solutions need time-costly preprocessing steps, are difficult to reproduce due to hyperparameter tuning, are hardly interpretable, and do not pay attention to epidemiological differences inherent to data coming from different centres, which can be critical. We propose using a multi-view heterogeneous Bayesian model (KSSHIBA) for the prediction of AR using MALDI-TOF MS data together with their epidemiological differences. KSSHIBA is the first model that removes the ad-hoc preprocessing steps that work with raw MALDI-TOF data. In addition, due to its Bayesian probabilistic nature, it does not require hyperparameter tuning, provides interpretable results, and allows exploiting local epidemiological differences between data sources. To test the proposal, we used data from 402 Klebsiella pneumoniae isolates coming from two different domains and 20 different hospitals located in Spain and Portugal. KSSHIBA outperforms current state-of-the-art approaches in antibiotic susceptibility prediction, obtaining a 0.78 AUC score in Wild Type classification and a 0.90 AUC score in Extended-Spectrum Beta-Lactamases (ESBL)+Carbapenemases (CP)-producers. The proposal consistently removes the need for ad-hoc preprocessing by working with raw MALDI-TOF data, which, in turn, reduces the time needed to obtain the results of the resistance mechanism in microbiological laboratories. The proposed model implementation as well as both data domains are publicly available.
- organism: human
- assay: metagenomics
- research focus: drug response / drug discovery
- approach: Bayesian inference
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra
H.-A. Nguyen, A. Y. Peleg, … N. Macesic·bioRxiv·Oct 25, 2023
- Improved MALDI-TOF MS based antimicrobial resistance prediction through hierarchical stratification
Caroline Weis, Bastian Rieck, … Karsten Michael Borgwardt·bioRxiv·Apr 13, 2022
- Direct Antimicrobial Resistance Prediction from clinical MALDI-TOF mass spectra using Machine Learning
- Improved prediction of antimicrobial resistance in Klebsiella pneumoniae using machine learning
Jordi Sevilla, Fernando Gónzález‐Candelas, Neris García‐González·bioRxiv·Dec 10, 2024
- Effect of Data Heterogeneity in Clinical MALDI-TOF Mass Spectra Profiles on Direct Antimicrobial Resistance Prediction through Machine Learning
Youngjun Park, Michael Weig, … Anne-Christin Hauschild·bioRxiv·Oct 18, 2024
- Elucidating Resistance Mechanisms in Staphylococcus epidermidis: A High-Performing MALDI-TOF MS-Based Proteomic Approach for Predictive Modeling
Michael Ren, Qiang Ke Chen, Jing Zhang·Scientific ReportsPeer-reviewed·Oct 15, 2024